ADCTVSGTBP• 28 Days (Normalized)
ADCT vs GTBP (ADC Therapeutics SA vs GT Biopharma Inc.)
Showing Closing Date Range from Sep 1 to Sep 29, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ADCT Performance $1.23
-0.81%
ADC Therapeutics SA
Normalized Baseline0.00%
GTBP Performance $6.88
+2278.89%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-2279.7 pts
GTBP outperforming by 2279.70 percentage points
ADCTGTBP
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ADCT GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | ADCT Price | ADCT Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $1.23 | -0.81% | $6.88 | +2278.89% | -2279.70% |
| Sep 28, 2026 | $1.26 | +1.61% | $6.80 | +2252.94% | -2251.33% |
| Sep 25, 2026 | $1.27 | +2.42% | $6.89 | +2284.08% | -2281.66% |
| Sep 24, 2026 | $1.29 | +4.03% | $6.83 | +2263.32% | -2259.29% |
| Sep 23, 2026 | $1.31 | +5.65% | $7.10 | +2356.75% | -2351.10% |
| Sep 22, 2026 | $1.23 | -0.81% | $- | - | |
| Sep 21, 2026 | $1.12 | -9.68% | $7.18 | +2384.43% | -2394.11% |
| Sep 18, 2026 | $1.05 | -15.32% | $7.16 | +2377.51% | -2392.83% |
| Sep 17, 2026 | $1.06 | -14.52% | $7.49 | +2491.70% | -2506.22% |
| Sep 16, 2026 | $1.05 | -15.32% | $7.81 | +2602.42% | -2617.74% |
| Sep 15, 2026 | $1.09 | -12.10% | $9.00 | +3014.19% | -3026.29% |
| Sep 14, 2026 | $1.11 | -10.48% | $11.63 | +3924.22% | -3934.70% |
| Sep 11, 2026 | $1.07 | -13.71% | $8.61 | +2879.24% | -2892.95% |
| Sep 10, 2026 | $1.11 | -10.48% | $6.18 | +2038.41% | -2048.89% |
| Sep 09, 2026 | $1.22 | -1.61% | $5.98 | +1969.20% | -1970.81% |
Page 1 of 2